Project Lead: Claudia Wild
Authors: Daniel Fabian, Claudia Wild
Publication: January 2026
Language: English
Article 57 of the new Medicines Directive stipulates a reporting obligation for public contributions to the R&D of medicinal products. This handbook presents the HI-PRIX framework for systematically identifying and documenting public contributions to pharmaceutical R&D across eight categories spanning basic research through post-market evidence generation. Our analysis reveals that the public is not a part of the innovation ecosystem but the main driver of it.